These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20585055)

  • 61. Lean-scaled weight: a proposed weight scalar to calculate drug doses for obese patients.
    Friesen JH
    Can J Anaesth; 2013 Feb; 60(2):214-5. PubMed ID: 23192695
    [No Abstract]   [Full Text] [Related]  

  • 62. The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug Development.
    Moore KT; Zannikos PN; Masters JC; Willmann S; Shen J; Frost C
    J Clin Pharmacol; 2023 Nov; 63 Suppl 2():S78-S84. PubMed ID: 37942912
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improving Medication Dosing in the Obese Patient.
    Erstad BL
    Clin Drug Investig; 2017 Jan; 37(1):1-6. PubMed ID: 27599484
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medication Dosage in Overweight and Obese Children.
    Matson KL; Horton ER; Capino AC;
    J Pediatr Pharmacol Ther; 2017; 22(1):81-83. PubMed ID: 28337087
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Medication Dosing for Children With Overweight and Obesity.
    Matson KL; Horton ER; Capino AC
    J Pediatr Pharmacol Ther; 2024 Oct; 29(5):550-553. PubMed ID: 39411409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perioperative Acetaminophen Dosing in Obese Children.
    Anderson BJ; Cortinez LI
    Children (Basel); 2023 Mar; 10(4):. PubMed ID: 37189874
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetic considerations in the obese.
    Leykin Y; Miotto L; Pellis T
    Best Pract Res Clin Anaesthesiol; 2011 Mar; 25(1):27-36. PubMed ID: 21516911
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine.
    Mortlock R; Smith V; Nesci I; Bertoldi A; Ho A; El Mekkawi Z; Kakuzada L; Williams K; Pont L; De Rubis G; Dua K
    Chem Biol Interact; 2023 Feb; 371():110351. PubMed ID: 36640929
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.
    Pai MP
    Clin Pharmacol Ther; 2021 Apr; 109(4):942-951. PubMed ID: 33523485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Status Toward the Implementation of Precision Dosing in Children.
    Barrett JS; Barrett RF; Vinks AA
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S36-S51. PubMed ID: 34185896
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ideal body weight in the precision era: recommendations for prescribing in obesity require thought for computer-assisted methods.
    Appelbaum N; Rodriguez-Gonzalvez C; Clarke J
    Arch Dis Child; 2020 May; 105(5):516-517. PubMed ID: 31831470
    [No Abstract]   [Full Text] [Related]  

  • 72. Bridging the gap: a review of dose investigations in paediatric investigation plans.
    Hampson LV; Herold R; Posch M; Saperia J; Whitehead A
    Br J Clin Pharmacol; 2014 Oct; 78(4):898-907. PubMed ID: 24720849
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Product Labeling of Drugs Commonly Administered to Children and Adults with Obesity.
    Zimmerman KO; Benjamin DK; Becker ML; Anand R; Hornik CP
    Pharm Regul Aff; 2019; 8(1):. PubMed ID: 37220561
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities.
    Vaidyanathan J; Fletcher EP; Ramamoorthy A; Madabushi R; Burckart GJ
    J Clin Pharmacol; 2023 Nov; 63 Suppl 2():S10-S17. PubMed ID: 37942907
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Model-Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory Perspective.
    Pan X; Wang L; Liu J; Earp JC; Yang Y; Yu J; Li F; Bi Y; Bhattaram A; Zhu H
    J Clin Pharmacol; 2023 Nov; 63 Suppl 2():S65-S77. PubMed ID: 37942906
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Difficulties with numeracy need to be picked up early in training.
    Stockwell F
    Nurs Stand; 2014 Nov; 29(12):35. PubMed ID: 25408044
    [No Abstract]   [Full Text] [Related]  

  • 77. Clinical Consequences of Altered Drug Disposition in Obesity: Call for Change.
    Bruno CD; Greenblatt DJ; Harmatz JS; Chow CR
    J Clin Pharmacol; 2023 Nov; 63 Suppl 2():S25-S34. PubMed ID: 37942910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Medications and Quality Improvement: Both Need the Right Dose to Be Effective.
    Boonyasai RT
    Qual Manag Health Care; 2019; 28(3):186-187. PubMed ID: 31246783
    [No Abstract]   [Full Text] [Related]  

  • 79. Modern pharmacological treatment of obese patients.
    May M; Schindler C; Engeli S
    Ther Adv Endocrinol Metab; 2020; 11():2042018819897527. PubMed ID: 32030121
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?
    Van Driest SL; Choi L
    Clin Pharmacol Ther; 2019 Jul; 106(1):84-86. PubMed ID: 30942897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.